Abstract
Central nervous system (CNS) involvement is a rare but almost fatal complication of diffuse large B-cell lymphoma (DLBCL). There is no consensus on the optimal CNS risk model and prophylaxis treatment. We conducted in all FIL centers a web-based survey, focused on algorithms used in routine practice to identify DLBCL patients at high CNS risk involvement. We collect the centers’ characteristics and the disease incidence, the CNS risk assessment and the diagnostic method and finally the type of prophylaxis used. Sixty-three out of 110 centers fulfilled the survey. 46% treat >30 DLBCL/years (yrs) and 40% 11-30 cases/yrs. In the last 5 yrs, 6% of centers reported >10 DLBCL with CNS and systemic localization at the diagnosis, 30% reported 4-10 cases and 48% reported 4 in 21% of centers, whereas in 56% of centers this procedure was performed in patients with either CNS-IPI >4 or with high-risk extranodal site. Patients with double\triple hit lymphoma, with double/triple + ABC and double expresser lymphomas were considered at high CNS risk in 44%, 49% and 49% of centers, respectively. CNS disease status was assessed by CSF evaluation and imaging in 79% and 73% of centers, respectively. CNS prophylaxis consisted of intrathecal Methotrxate (MTX) in 58% of centers and in HD-MTX (1.5 to 3 gr/sqm) in 40% of centers. This survey shows real-life practice and the differences in diagnosis and prophylaxis of CNS in DLBCL patients.
Highlights
Central nervous system (CNS) Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)
They suggested that CNS prophylaxis should be offered to patients with any factor among high [4,5,6] CNS-IPI, involvement of three or more extranodal sites irrespective of CNSIPI, involvement of certain extranodal organs, and in intravascular large B-cell lymphoma; they advise to consider CNS prophylaxis in patients with involvement of breast or uterus
We designed a National survey focused on algorithms used in routine practice to identify diffuse large B-cell lymphoma (DLBCL)
Summary
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL). CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Literature on CNS prophylaxis in DLBCL [3,4,5,6,7,8,9,10] is mostly based on retrospective studies, where high-risk patients were defined usually by homemade, not validated prognostic factors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.